Trevena (TRVN) PT Lowered to $3 at JMP Securities 'reflecting equity dilution' Apr 2, 2024 05:41AM
Trevena to Participate at the JMP Securities Life Sciences Conference Jun 10, 2022 07:00AM
Trevena to Present at the JMP Securities Life Sciences Conference Jun 9, 2021 07:00AM
Trevena to Present at the Virtual JMP Securities CNS Forum Aug 14, 2020 01:42PM
Trevena (TRVN) Prices $50M Public Offering of Common Stock at $2.30/sh Aug 12, 2020 09:28AM


Aug 12, 2020 09:27AM Trevena Announces Pricing of $50 Million Public Offering of Common Stock
Aug 10, 2020 01:18PM Trevena (TRVN) PT Raised to $6 at JMP Securities, After FDA Approval Received
May 29, 2019 04:01PM Trevena to Participate in Upcoming Conferences in June 2019
Oct 12, 2018 05:32AM Trevena (TRVN) PT Lowered to $4 at JMP Securities
Oct 10, 2018 09:40AM Trevena (TRVN): JMP Securities Continues to See AdComm Vote in Favor of Oliceridine
Jun 2, 2017 07:00AM Trevena to Present at Investor Conferences in June
Sep 16, 2015 09:23AM Trevena, Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Sep 11, 2015 09:01AM Trevena (TRVN) Prices 6.5M Common Stock Offering at $9.75/Share
Sep 11, 2015 09:00AM Trevena, Inc. Announces Pricing of Underwritten Offering of Common Stock
Jun 17, 2015 07:00AM Trevena CEO to Present at the 2015 JMP Securities Life Sciences Conference
Dec 5, 2014 07:38AM Trevena (TRVN) 11.25M Offering Prices at $4/Share
Feb 26, 2014 08:36AM JMP Securities Starts Trevena (TRVN) at Market Outperform, PT $18
Jan 31, 2014 10:00AM Trevena (TRVN) IPO Opens Roughly Flat
Jan 31, 2014 09:44AM Trevena (TRVN) Prices 9.25M Common IPO at $7/Share
Oct 9, 2013 03:42PM Trevena (TRVN) Files $86.25M IPO